Abstract
Rhodotorula sp. are commensal yeasts that may cause opportunistic infections. There have been only a few case reports of Rhodotorula fungemia in children with cancer, and in all of them the patients had a central venous catheter inserted. The authors report three nonfatal cases of fungemia by Rhodotorula in patients with post-chemotherapy neutropenia. Two of three patients required catheter removal, and a response was achieved with systemic antifungal therapy. Aggressive therapy may be required for selected high-risk patients.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Antifungal Agents / therapeutic use*
-
Antineoplastic Agents / therapeutic use
-
Catheterization, Central Venous / adverse effects
-
Catheters, Indwelling / microbiology
-
Child
-
Female
-
Fungemia / drug therapy
-
Fungemia / etiology*
-
Humans
-
Leukemia, Promyelocytic, Acute / complications
-
Leukemia, Promyelocytic, Acute / drug therapy
-
Leukemia, Promyelocytic, Acute / microbiology
-
Lymphoma, T-Cell / complications
-
Lymphoma, T-Cell / drug therapy
-
Lymphoma, T-Cell / microbiology
-
Rhodotorula / isolation & purification*
-
Sarcoma, Ewing / complications
-
Sarcoma, Ewing / drug therapy
-
Sarcoma, Ewing / microbiology
Substances
-
Antifungal Agents
-
Antineoplastic Agents